story of the week
Change in Albuminuria as a Surrogate Endpoint for Cardiovascular and Renal Outcomes in Patients With Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Change in albuminuria as a surrogate endpoint for cardiovascular and renal outcomes in patients with diabetes
Diabetes Obes Metab 2023 Jun 01;25(6)1434-1443, BF PalmerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.